We feel now is a pretty good time to analyse Immix Biopharma, Inc.'s ( NASDAQ:IMMX ) business as it appears the ...

Full Detection Through Resolution Stack Demonstrated Across Risk, Monitoring, and ResponseDetroit, Michigan--(Newsfile Corp. ...

Immix Biopharma, Inc. (IMMX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...

Immix Biopharma Inc (NASDAQ: IMMX) shares are trading marginally lower Monday morning after the clinical-stage biotech filed a new shelf registration statement on Form S-3 with the U.S. Securities and ...

Fintel reports that on February 9, 2026, Mizuho initiated coverage of Immix Biopharma (NasdaqCM:IMMX) with a Outperform recommendation. Analyst Price Forecast Suggests 81.60% Upside As of February 4, ...

Immix Biopharma announced significant results from its NEXICART-2 Phase 1/2 clinical trial of NXC-201 at the ASCO 2025 conference, achieving a complete response (CR) rate of 70% in patients with ...

Absence of neurotoxicity of any grade in low-volume disease to-date highlights a significant safety profile for NXC-201, which is crucial for patient acceptance and regulatory approval. Company is on ...

CHARLOTTE, N.C.—Immix, a global provider of commercial central station and remote SOC software for managed video and security services, has announced the addition of Kim Flitter as its new global CFO.

IRVINE, Calif. – Cloud-based VMS provider Arcules has announced that its integration with Immix Central Station (IMMIX CS) and Guard Force (IMMIX GF) is now available. Arcules said that the ...